Atlas Trials

Phosphodiesterase Type 5 Inhibitors in Patients With Group 2 Pulmonary Hypertension

Clinical trial NCT06350773 · COMPLETED

Trial details

NCT number
NCT06350773
Sponsor
Beni-Suef University
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Group 2 Pulmonary HypertensionCpcPH
Start date
2023-03-10
Primary completion
2025-10-25
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.